I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

The elderly experiences more chronic medical conditions than younger people, takes more medications, and is more likely to suffer from the adverse effects of multiple medications. Potentially inappropriate medications (PIMs), defined as those adverse risks exceeding their health benefits when compared with alternative therapies,\[[@ref1]\] are a preventable cause of negative clinical and economic consequences in older people.\[[@ref2][@ref3][@ref4][@ref5]\]

With aging, geriatric patients, especially in very old age, are more vulnerable to drug-related problems, including PIM and potential adverse drug reactions.\[[@ref6][@ref7][@ref8]\] The Beers criteria are one of the most popular guidelines for PIM use in elderly, which was initially released in 1991 and updated in 1997, 2003, and 2012.\[[@ref9][@ref10][@ref11]\] Research has documented widespread PIM prevalence in elderly persons, which ranged from 9.8% to 46.5%.\[[@ref5][@ref12][@ref13][@ref14][@ref15]\] However, to our knowledge, there are not any kind of data to show the comparison of PIM prevalence between the elderly aged 65--79 years and those aged 80 years or older.

In this study, we investigated the different prevalence of PIM use in elderly inpatients between aged 65--79 years and aged 80 years or older, who were discharged from the Geriatric Department of West China Hospital using the 2012 Beers criteria. We found inpatients aged 80 years or older have more PIM use and encounter more potential inappropriate prescription of benzodiazepines, drugs with strong anticholinergic properties, megestrol, antipsychotics, theophylline, and aspirin than patients aged 65--79 years.

M[ETHODS]{.smallcaps} {#sec1-2}
=====================

Study design and ethical considerations {#sec2-1}
---------------------------------------

This was a retrospective cross-sectional study conducted in Geriatric Department of West China Hospital, a nonprofit tertiary care academic hospital. The study protocol was approved by the Research Ethics Committee of Sichuan University before the commencement of the study (ChiCTR-ECS-14004441).

Setting and participants {#sec2-2}
------------------------

From October 2012 to April 2013, all patients aged 65 years or older who were discharged from the geriatric wards in West China Hospital were sampled for the study. Then, the subjects were divided into two groups as patients aged 65--79 years, and patients aged 80 years or older. All medications consumed on an as-needed basis; vitamin or mineral supplement, drug for topical use, and herbal medicines were not included in this study. The patients were excluded if no medication was used or the medication administration records were unavailable or incomplete.

Data collection {#sec2-3}
---------------

The electronic medical records (EMRs) of the patients were retrieved from the Information Center of West China Hospital, and the information obtained was transferred into a prepared spreadsheet. Retrieved information included age, gender, length of stay, prognosis (discharge or death), the total hospital charges, expenses for medicine, the primary medical conditions (diagnosis), and the prescribed drugs and dosages.

Study outcomes {#sec2-4}
--------------

The PIM analysis included all subjects who were eligible for this study. To investigate the difference of PIM use occurrence between patients aged 65--79 years and those aged 80 years or older, a full-length updated American Geriatric Society version (2012) of the Beers criteria was downloaded and printed out. All of the drugs included in the Beers criteria were assessed according to their availability in China. The prescribed medications were then assessed using these criteria to determine their appropriateness. To minimize interpretation bias, two raters were trained to use Beers criteria. Each rater evaluated the data set independently, and all disagreements were resolved through discussion.

Statistical analysis {#sec2-5}
--------------------

Data generated from the EMRs were recorded on a spreadsheet and analyzed using SPSS version 16.0 (SPSS Inc., USA). Descriptive statistics was expressed as mean or median, frequencies or percentages. The list of PIMs found among patients was compiled and calculated as percentages. Chi-square test was used to compare categorical data, and the Student\'s *t*-test or nonparametric test was applied to compare continuous variables for mean or median, respectively. Logistic regression analysis was carried out to identify the independent factors associated with PIM use--univariate analysis was carried out, and the variables which were statistically significant at α level of 0.1 were included in multivariate stepwise regression. *P* value of \<0.05 was considered statistically significant.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Demographics of participant patients {#sec2-6}
------------------------------------

This study included a total of 1796 participants aged 65 years or older. Ten patients were excluded from the analysis because they were not prescribed any medication at the time of hospitalization. Among 1786 patients, 618 (34.4%) patients aged 65--79 years (74 ± 4 years) and 1178 (65.6%) patients were 80-year-old and above (85 ± 4 years) \[[Table 1](#T1){ref-type="table"}\].

###### 

Characteristics of the study subjects

  Characteristics                                   Age (years)               Statistical values        *P*        
  ------------------------------------------------- ------------------------- ------------------------- ---------- ---------
  Gender                                                                                                           
   Men, *n* (%)                                     420 (68.0)                925 (78.5)                24.04\*    \<0.001
   Women, *n* (%)                                   198 (32.0)                253 (21.5)                24.04\*    \<0.001
  Number of diagnostic disease (mean ± SD)          5.5 ± 2.1                 6.5 ± 1.9                 10.34^†^   \<0.001
  Number of prescribed medication (mean ± SD)       14.2 ± 9.9                17.6 ± 10.4               6.68^†^    \<0.001
  Length of hospital stay, days, and median (IQR)   16 (11--28)               23 (14--34)               5.91\*     \<0.001
  Hospitalization cost, \$, median (IQR)            2699.8 (1583.1--5323.7)   3558.4 (2057.8--6818.8)   4.05\*     \<0.001
  Death, *n* (%)                                    26 (4.2)                  78 (6.6)                  4.33\*     0.037
  Frequency of PIM, *n* (%)                         268 (43.4)                686 (58.2)                40.18\*    \<0.001

\**χ*^2^ values; ^†^*t* values. PIM: Potentially inappropriate medication; SD: Standard deviation; IQR: Interquartile range.

Co-morbidity and outcome of death {#sec2-7}
---------------------------------

Patients aged 80 years or older had more co-morbidities than those aged 65--79 years (6.5 ± 1.9 vs. 5.5 ± 2.1, *P* \< 0.001) \[[Table 1](#T1){ref-type="table"}\]. Patients aged 80 years or older were greater vulnerability to hypertension, infectious disease, lower urinary tract symptoms (LUTS)/benign prostatic hyperplasia (BPH), chronic obstructive pulmonary disease (COPD), insomnia, coronary heart disease, chronic constipation, cerebrovascular disease, osteoporosis, dementia, chronic kidney disease (CKD), history of fractures, Parkinson\'s disease, and chronic seizures (all with *P* \< 0.05) \[[Table 2](#T2){ref-type="table"}\]. In all of participants, 104 patients died finally. Seventy-eight (6.6%) of them aged 80 years or older, but 26 (4.2%) of them aged 65--79 years (*P* \< 0.001) \[[Table 1](#T1){ref-type="table"}\].

###### 

Prevalence of diagnosis in patients, *n* (%)

  Diagnosis                 Age (years)   *χ*^2^       *P*     
  ------------------------- ------------- ------------ ------- ---------
  Hypertension              335 (54.2)    807 (68.5)   35.79   \<0.001
  Infectious disease        230 (37.2)    507 (43.0)   5.68    0.017
  LUTS/BPH                  180 (29.1)    504 (42.8)   32.07   \<0.001
  COPD                      172 (27.8)    496 (42.1)   35.35   \<0.001
  Insomnia                  173 (28.0)    459 (39.0)   21.39   \<0.001
  Coronary heart disease    153 (24.8)    403 (34.2)   16.95   \<0.001
  Chronic constipation      132 (21.4)    406 (34.5)   33.18   \<0.001
  Cerebrovascular disease   156 (25.2)    362 (30.7)   5.95    0.015
  Osteoporosis              55 (8.9)      164 (13.9)   9.55    0.002
  Dementia                  19 (3.1)      123 (10.4)   30.21   \<0.001
  CKD                       28 (4.5)      85 (7.2)     4.96    0.026
  History of fractures      18 (2.9)      89 (7.6)     15.59   \<0.001
  Parkinson's disease       9 (1.5)       59 (5.0)     14.04   \<0.001
  Chronic seizures          3 (0.5)       20 (1.7)     4.71    0.030
  DM/IGT                    185 (29.9)    368 (31.2)   0.32    0.570
  Cancer                    142 (23.0)    267 (22.7)   0.02    0.881
  Heart failure             99 (16.0)     216 (18.3)   1.50    0.220
  Atrial fibrillation       38 (6.1)      101 (8.6)    3.34    0.068
  Anxiety/depression        41 (6.6)      86 (7.3)     0.27    0.601
  Delirium                  7 (1.1)       17 (1.4)     0.30    0.586

LUTS/BPH: Lower urinary tract symptoms/benign prostatic hyperplasia; COPD: Chronic obstructive pulmonary disease; CKD: Chronic kidney disease; DM/IGT: Diabetes mellitus/impaired glucose tolerance.

Potentially inappropriate medication use {#sec2-8}
----------------------------------------

Compared with patients aged 65--79 years, patients aged 80 years or older were prescribed more medications (17.6 ± 10.4 vs. 14.2 ± 9.9). About 58.2% (686) of the patients aged 80 years or older consumed at least one PIM. However, only 43.4% (268) of the patients aged 65--79 years consumed at least one PIM (χ;^2^ = 40.18, *P* \< 0.001) \[[Table 1](#T1){ref-type="table"}\]. [Table 3](#T3){ref-type="table"} lists top 10 of PIM categories using the 2012 Beers criteria prescribed in each group respectively. Notably, more patients aged 80 years or older were prescribed with benzodiazepines, drugs with strong anticholinergic properties, megestrol, antipsychotics, theophylline, and aspirin. When categorized by gender, female patients encountered more PIMs than male (54.5% vs. 52.6%, *P* \< 0.05). However, except drugs with strong anticholinergic properties and non-COX-selective nonsteroidal anti-inflammatory drugs (NSAIDs), other prescriptions in top 10 PIMs were not different between female and male patients \[[Table 4](#T4){ref-type="table"}\].

###### 

Prevalence of PIMs identified using 2012 Beers criteria

  Name of PIM                                    Number of elderly receiving drugs, *n* (%)   *χ*^2^       *P*      
  ---------------------------------------------- -------------------------------------------- ------------ -------- ---------
  Benzodiazepines                                169 (27.3)                                   454 (38.5)   22.418   \<0.001
  Drugs with strong anticholinergic properties   35 (5.7)                                     145 (12.3)   19.851   \<0.001
  Megestrol                                      35 (5.7)                                     131 (11.1)   14.39    \<0.001
  Antipsychotics                                 14 (2.3)                                     89 (7.6)     20.981   \<0.001
  Theophylline                                   22 (3.6)                                     80 (6.8)     7.901    0.005
  Non-COX-selective NSAIDs, oral                 31 (5.0)                                     66 (5.6)     0.273    0.661
  Spironolactone                                 31 (5.0)                                     56 (4.8)     0.061    0.806
  Metoclopramide                                 37 (6.0)                                     49 (4.2)     2.969    0.085
  Aspirin                                        0 (0.0)                                      41 (3.5)     19.547   \<0.001
  Antiarrhythmic drug (Class Ia, Ic, III)        12 (1.9)                                     20 (1.7)     0.138    0.710

PIM: Potentially inappropriate medication; COX: Cyclooxygenase; NSAIDs: Nonsteroidal anti-inflammatory drugs.

###### 

Prevalence of PIMs in different gender identified using 2012 Beers criteria

  Name of PIM                                    Number of elderly receiving drugs, *n* (%)   *χ*^2^       *P*      
  ---------------------------------------------- -------------------------------------------- ------------ -------- -------
  Benzodiazepines                                456 (33.9)                                   167 (37.0)   1.456    0.228
  Drugs with strong anticholinergic properties   153 (11.4)                                   27 (6.0)     4.819    0.028
  Megestrol                                      136 (10.1)                                   30 (6.7)     2.581    0.108
  Antipsychotics                                 84 (6.2)                                     19 (4.2)     1.176    0.278
  Theophylline                                   81 (6.0)                                     21 (4.7)     1.101    0.294
  Non-COX-selective NSAIDs, oral                 77 (5.7)                                     20 (4.4)     10.876   0.001
  Spironolactone                                 64 (4.8)                                     23 (5.1)     0.085    0.770
  Metoclopramide                                 62 (4.6)                                     24 (5.3)     0.375    0.540
  Aspirin                                        34 (2.5)                                     8 (1.8)      0.841    0.359
  Antiarrhythmic drug (class Ia, Ic, III)        21 (1.6)                                     11 (2.4)     1.487    0.223

PIM: Potentially inappropriate medication; COX: Cyclooxygenase; NSAIDs: Nonsteroidal anti-inflammatory drugs.

Health economics outcomes {#sec2-9}
-------------------------

Patients aged 80 years or older had longer hospital stays (23 \[14--34\] vs. 16 \[11--28\] days, *P* \< 0.001). In all the participants, median hospitalization cost was \$3244.9 (\$1886.3--\$6174.7). Patients aged 80 years or older showed higher hospitalization cost (\$3558.4 \[\$2057.8--\$6818.8\] vs. \$2699.8 \[\$1583.1--\$5323.7\], *P* \< 0.001), compared with patients aged 65--79 years \[[Table 1](#T1){ref-type="table"}\].

Factors associated with potentially inappropriate medication use {#sec2-10}
----------------------------------------------------------------

In univariate analysis, we included the variables such as age, gender, number of prescribed medication, length of hospital stay, hospitalization cost, and number of diagnostic diseases. Among variables, the multivariate Logistic regression detected that the characteristics such as female gender (odds ratio \[*OR*\] = 1.411, 95% confidence interval \[*CI*\] = 1.106--1.799), age (*OR* = 1.017, 95% *CI* = 1.001--1.033), number of diagnostic disease (*OR* = 1.291, 95% *CI* = 1.215--1.370), and number of prescribed medication (*OR* = 1.082, 95% *CI* = 1.064--1.100) were significantly associated with PIM exposure \[[Table 5](#T5){ref-type="table"}\].

###### 

Multivariate analysis of variables independently associated with PIM use

  Factor associated with PIM use   *OR* (95% *CI*)        *P*
  -------------------------------- ---------------------- ---------
  Gender (women)                   1.411 (1.106--1.799)   0.006
  Age                              1.017 (1.001--1.033)   0.043
  Number of diagnostic disease     1.291 (1.215--1.370)   \<0.001
  Number of prescribed medicine    1.082 (1.064--1.100)   \<0.001

PIM: Potentially inappropriate medication; 95% *CI*: 95% confidence interval; *OR*: Odds ratio.

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

Inappropriate use of medications in elderly patients has not caught attention widely in China until recently. Our data showed that patients aged 80 years or older encountered more PIM use (58.2%) than patients aged 65--79 years (43.4%) identified by 2012 Beers criteria. In the most commonly taken PIMs, patients aged 80 years or older have been uncovered to encounter more prescription of benzodiazepines, drugs with strong anticholinergic properties, megestrol, antipsychotics, theophylline, and aspirin than patients aged 65--79 years.

Comorbidity and potentially inappropriate medication {#sec2-12}
----------------------------------------------------

Several data from our study could explain the phenomena. First of all, patients aged 80 years or older had more co-morbidities (6.5 ± 1.9) than younger (5.5 ± 2.1). Patients aged 80 years or older suffered more from COPD, LUTS/BPH, insomnia, chronic constipation, osteoporosis, dementia, CKD, history of fractures, Parkinson\'s disease, and chronic seizures \[[Table 2](#T2){ref-type="table"}\]. As the result, increasing number of multimorbidity with age often makes it necessary to prescribe several drugs for one patient at a time. Gallagher *et al*.\[[@ref16]\] found that the average number of drugs prescribed to 65-year-old patients is five simultaneously and prescription peaks in the 75--84 years old group. Hence, these frailty senile patients were more vulnerable to damage with PIMs. Similarly, patients aged 80 years or older in our study were more often prescribed with inhaled anticholinergic agents and theophylline to treat COPD, benzodiazepines to improve insomnia, and antipsychotics to control behavioral problems of dementia and so on. It has been shown that anticholinergic drugs could increase the risk for dementia and mortality.\[[@ref17]\] Benzodiazepines and antipsychotics can significantly increase the risk of fall, fracture, and mortality in the elderly.\[[@ref18][@ref19][@ref20][@ref21][@ref22]\] Unfortunately, these medications are often prescribed by physicians in China due to the lack of necessary vigilance of PIMs in elderly.

Polypharmacy and potentially inappropriate medication {#sec2-13}
-----------------------------------------------------

Second, as the result of co-morbidities,\[[@ref23][@ref24]\] patients aged 80 years or older were prescribed with more medications (17.6 ± 10.4) than younger (14.2 ± 9.9). Polypharmacy is particularly common among the elderly, making them especially susceptible to drug-drug interactions (DDIs). Polypharmacy has been shown to significantly associate with PIM and DDIs.\[[@ref25][@ref26][@ref27]\] According to a study in 2007, DDIs caused 4.8% of hospital admissions among the elderly, increasing their risk nearly 8.5-fold relative to the general population.\[[@ref28]\] DDIs also contribute to higher cost and prolonged duration of hospital stays.\[[@ref29]\]

Benzodiazepines were the most common potentially inappropriate medication {#sec2-14}
-------------------------------------------------------------------------

Finally with aging, more elderly were troubled with insomnia and depression. To solve this problem, benzodiazepines were commonly used in hospitalized elderly by physicians. Our data suggested that the most commonly encountered PIM in this study was benzodiazepine. Older patients (age ≥80 years) were prescribed with more benzodiazepine than younger (65 years ≤ age \< 80 years), which makes our result different from other studies. Keith *et al*.\[[@ref2]\] and Fadare *et al*.\[[@ref30]\] discovered that NSAIDs were the most common PIM use in the elderly patients in Italy and Nigeria, respectively. However, Oliveira *et al*.\[[@ref25]\] showed that short-acting nifedipine was the most one in Brazilian. It might due to the difference of doctor\'s prescription behaviors among these countries. Other potential factors of high prevalence of benzodiazepines use in hospitalized elderly in China are often solely for the convenience for the staff, which were also found in nursing home in the USA before.\[[@ref31][@ref32]\] Few of doctors are willing to try nondrug therapy to help elderly patients solve problems such as insomnia or delirium before prescribing medication. On the other hand, many of the elderly with co-morbidities are unwilling to try nondrug method and are convinced that it is the best choice to take medicine.

Limitations {#sec2-15}
-----------

Several limitations should be noted in this study. First, updated 2012 Beers criteria are utilized to screen PIM in this study due to the lack of national criteria.\[[@ref11]\] Some authors have formulated new explicit and implicit criteria that have been adapted for a specific country.\[[@ref25][@ref33][@ref34][@ref35][@ref36]\] Beers criteria allow for a relative assessment of drug use risk in the elderly but do not address other type of potential PIMs that are not unique to aging, including dosing of primarily renal cleared medications, DDIs, therapeutic duplication, and traditional Chinese medicine. Second, this is a retrospective cross-sectional study. All of the data were gathered from EMR, and we could not rule out several interference factors such as accuracy and integrity of diagnosis. Third, its single-center nature seems to influence adversely the generalizability of the results in the mainland of China. However, the study uncovered the prevalence of PIM use in different age China elderly. The EMR of the inpatients in West China Hospital are complete and detailed. Finally, this study does not describe the adverse drug interaction caused by PIM use because it is a retrospective cross-sectional study and analysis was based on EMR-reported data. It is difficult to review and predicate the relationship between adverse outcome and PIM use exactly.

In conclusion, the finding from this study revealed that inpatients aged 80 years or older encountered more PIM use than those aged 65--79 years. PIMs defined by the 2012 Beers criteria have been shown to be associated with female gender, age, polypharmacy, and co-morbidities. Taking into account the increasing elderly population and the importance of the health program for the care of this population, all of the physicians in China must pay more attention to the information about PIM and carefully choose drugs that are safer for the elderly, especially the elderly aged 80 years or older.
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